Skip to Main Content
Home
Search
Study Topics
Glossary
List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 18 studies with search of:
"Narcolepsy"
Hide studies that are not seeking new volunteers.
Display Options
Rank
Status
Study
1
Completed
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
Condition:
Narcolepsy
Interventions:
Drug: Xyrem + Modafinil Placebo; Drug: Xyrem Placebo + Modafinil Placebo; Drug: Xyrem Placebo + Modafinil at established dose; Drug: Xyrem + Modafinil at established dose
2
Completed
Safety and Efficacy Study of CEP-10953 in the Treatment of Excessive Sleepiness Associated With Narcolepsy
Condition:
Narcolepsy
Intervention:
Drug: CEP-10953
3
Recruiting
Body Weight Regulation in Patients With Narcolepsy
Condition:
Narcolepsy
Intervention:
4
Completed
PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions:
Narcolepsy; Sleep Apnea, Obstructive
Intervention:
Drug: Modafinil
5
Completed
Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
Condition:
Narcolepsy
Intervention:
Drug: Xyrem (sodium oxybate) oral solution
6
Completed
Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition:
Narcolepsy
Intervention:
Drug: Modafinil
7
Terminated
Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
Condition:
Narcolepsy
Intervention:
Drug: GSK189254
8
Completed
A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy
Condition:
Narcolepsy
Interventions:
Drug: JNJ-17216498; Drug: JNJ-17216498; Drug: Modafinil
9
Completed
CEP-10953 for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Conditions:
Narcolepsy; Sleep Apnea, Obstructive; Sleep Apnea Syndromes; Shift-Work Sleep Disorder
Intervention:
Drug: CEP-10953
10
Completed
Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions:
Excessive Day Time Sleepiness; Narcolepsy
Intervention:
Drug: Armodafinil
11
Completed
Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
Condition:
Narcolepsy
Intervention:
Drug: sodium oxybate
12
Completed
Provigil (Modafinil) Study by Taiwan Biotech Co.
Conditions:
Narcolepsy; Cataplexy; Sleep Disorders; Hypersomnolence; Excessive Sleepiness
Intervention:
Drug: Modafinil
13
Completed
Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Conditions:
Excessive Daytime Sleepiness; Narcolepsy
Intervention:
Drug: PROVIGIL (modafinil)
14
Completed
Extension Study of the Safety and Efficacy of CEP-10953 in the Treatment of Patients With Excessive Sleepiness
Conditions:
Excessive Daytime Sleepiness; Narcolepsy
Intervention:
Drug: CEP-10953
15
Completed
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition:
Narcolepsy With Cataplexy
Intervention:
Drug: Sodium Oxybate (Xyrem)
16
Active, not recruiting
Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition
Condition:
Narcolepsy
Intervention:
Drug: Orexine A
17
Recruiting
Sleep Disorders of Patients With Diseases of the Nervous System
Conditions:
Hypersomnia; Narcolepsy; Nervous System Disease; Sleep Disorder
Intervention:
18
Enrolling by invitation
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Condition:
Narcolepsy
Intervention:
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feed for studies found by your search that were received in the last 14 days
Download Options
Back to top of Main Content